Novo Nordisk to buy Akero for up to $5.2 billion in new CEO's revival push (2025-10-09)
Novo Nordisk said on Thursday it would buy U.S.-based Akero Therapeutics for up to $5.2 billion to gain access to a promising liver disease drug candidate.